Navigation Links
PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil
Date:5/27/2009

RALEIGH, N.C., May 27 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of a Drug Safety Center in its Sao Paulo, Brazil office. Drug Safety Centers are a key component of PRA's Safety and Risk Management unit. They are staffed with drug safety professionals who are responsible for Serious Adverse Event and Adverse Drug Reaction management. Furthermore, our drug safety personnel support our clients in all other aspects of pharmacovigilance to ensure regulatory compliance.

PRA already operates two dedicated Drug Safety Centers, one in Charlottesville, VA, US and the other in Mannheim, Germany. The opening of the Drug Safety Center in Sao Paulo strengthens PRA's footprint in Latin America and provides additional global reporting capabilities. With drug safety professionals hired and trained, PRA is already executing safety project work from the Sao Paulo center and will continue to expand its global safety management offerings.

"The opening of the Sao Paulo Drug Safety Center enables us to expand our capabilities and level of service in Latin America and enhances our ability to provide standardized Drug Safety services globally, by growing and strengthening our overall safety team," noted Dr. Sabine Richter, PRA's Vice President of Safety and Risk Management. "This new center will allow us to create cost-effective and efficient global coverage that is enhanced with a local language and regulatory knowledge base. Both are key to our continued expansion of clinical trial and post-approval delivery in Latin America and globally."

"The growth of our drug safety services in Latin America is a component of PRA's continued global expansion to best support the new dimensions of drug development," added Steve Powell, Senior Vice President, Clinical Informatics & Late Phase Services. "PRA is committed to long-term patient safety and understands the increasing focus of regulatory bodies and in turn of our clients on the benefit risk profiles of medicinal products. PRA's expansion not only increases our breadth geographically, but also strengthens the depth of the services we provide to sponsors and patients."

PRA's Safety and Risk Management team offers comprehensive services throughout a product's life-cycle. PRA provides services to support EU-RMP, FDA-REMS, Annual Safety Reporting, IND Reports and a host of other services. In 2008 alone, PRA accomplished the following for its clients:

  • More than 18,000 individual safety reports
  • 3,000 Expedited Safety Reports to regulatory authorities
  • 250 Cumulative Safety Reports to regulatory authorities
  • 5 data integration and pooled analysis projects
  • Hosted 21 client pharmacovigilance audits
  • Contributed to 3 FDA Approvals

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: